Dec. 5, 2013—Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.
May. 23, 2013—David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men.
Jan. 30, 2013—A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.
Nov. 15, 2012—Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.
Aug. 30, 2012—Racial differences exist in quality surgical care, new research from VICC finds.
Aug. 23, 2012—A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
Aug. 2, 2012—Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.
Jul. 24, 2012—Targeting immune system proteins may keep prostate cancer from spreading to bone.
Feb. 3, 2012—Severity of cancer could be predicted by prostate size.
Sep. 22, 2011—These days, just about anyone who sees a pink lapel ribbon knows it symbolizes breast cancer awareness. But a light blue ribbon? Well, that’s another story. The symbol for prostate cancer awareness is far less recognizable than its feminine counterpart, just as the disease itself is far less in the public eye. Why is this...
Jun. 3, 2011—Low blood levels of magnesium are associated with more aggressive prostate cancer, a recent study suggests.
Feb. 22, 2011—The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds.